Table 4.

Treatment of Manifestations in Individuals with Hermansky-Pudlak Syndrome

Manifestation/ConcernTreatmentConsiderations/Other
Refractive errors
  • Correction of refractive errors to improve visual acuity
  • Aids (e.g., handheld magnifying devices, bioptic lenses) as needed
  • Preferential seating in school
  • Low vision consultant as needed
Recommend UV-blocking sunglasses.
Strabismus Surgery for strabismus is indicated when misalignment cannot be corrected by medical measures.Surgery is not usually required & is not always successful.
Skin Protection from sun to prevent burning, skin damage, & skin cancer:
  • Protective clothing (hats w/brims, long sleeves, pants, socks) for prolonged exposure
  • Sunscreen w/high SPF (45-50+) for sun-sensitive persons; SPF (15+) for less sun-sensitive persons
Recommendations are based on individual skin pigment & cutaneous response to sunlight. In very sun-sensitive persons, sun exposure of 5-10 mins can be damaging; in less sun-sensitive persons, exposure of ≥30 minutes is damaging.
Standard treatments for skin cancer
Bleeding
  • Thrombin-soaked Gelfoam® can be used on minor wounds that fail to clot spontaneously.
  • Recommend medical alert bracelet that explicitly describes the functional platelet defect, as the standard tests for bleeding dysfunction (e.g., platelet count, prothrombin time, partial thromboplastin time) are normal in those w/HPS.
Recommend bleeding mgmt plan in coordination w/coagulation specialist, schools, family, & primary care providers.
Epistaxis Humidifiers may ↓ frequency of nosebleeds.
Menorrhagia
  • Oral contraceptives & IUDs can ↓ menorrhagia.
  • Menorrhagia has been treated w/levonorgestrel-releasing intrauterine system [Kingman et al 2004] & recombinant factor VIIa [Lohse et al 2011].
Anti-fibrinolytics, such as aminocaproic acid & tranexamic acid, can ↓ severity of bleeding.
Surgical bleeding
  • For more invasive trauma, such as wisdom tooth extraction, DDAVP® (desmopressin acetate), 0.3 µg/kg in 50 mL of normal saline, can be given as a 30- to 60-min IV infusion just prior to procedure.
  • For extensive surgeries or protracted bleeding, platelet or RBC transfusions may be required.
  • For elective surgical procedures w/estimated moderate or greater blood loss, HLA-matched single-donor platelets should be used.
  • Recommend having platelets on standby for all surgical procedures w/risk of significant bleeding.
Not all affected persons respond to DDAVP®, & responsiveness testing is recommended. 1
Pulmonary fibrosis Maximize pulmonary function:
  • Prompt treatment of asthma & pulmonary infections
  • Influenza, pneumococcal, & COVID-19 vaccines
  • Regular moderate exercise
  • Optimized treatment for concomitant reactive airways disorders
Affected persons should be counseled to avoid all recreational inhalational products, chemical & physical substances (e.g., organic/inorganic fibers, volatile chemicals), & use of medications assoc w/drug-induced pulmonary fibrosis (e.g., methotrexate, bleomycin, amiodarone, nitrofurantoin).
Oxygen therapy for severe pulmonary diseaseOxygen therapy is life-sustaining for persons w/advanced-stage disease & helps forestall development of secondary pulmonary hypertension.
Bilateral or single-lung transplantation if appropriate 2
Colitis HPS-related colitis may respond to steroids & other anti-inflammatory agents. 3 Remicade® has also been used w/benefit. 4HPS-related colitis can affect upper intestinal structures & is assoc w/extraintestinal manifestations such as pyoderma gangrenosum.
Immunodeficiency Typically responsive to granulocyte colony-stimulating factorRecommend infection prevention plan in coordination w/infectious disease specialist, schools, family, & primary care providers.

From: Hermansky-Pudlak Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.